ADLiquid Antioxidant Colloidal

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.005491.04.15
Date of registration and renewal:09.04.2015
Dosage form: & nbspFLiquid in bottles of 237 ml.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes BAA sources of antioxidant substances and substances that affect energy metabolism Supplements that support the function of the cardiovascular system Supplements that promote the normalization of peripheral (capillary) blood circulation, incl. cerebral
Composition: & nbspIngredients: ascorbic acid, vitamin E, beta-carotene, niacinamide, B2, vitamin A, vitamin B6, zinc citrate, selenium aspartate, rutin, quercetin, hesperidin, evening primrose oil, grape seed extract, rosemary officinal extract, ginkgo biloba leaf extract , extract of Reishi mushrooms, di-methyl glycine, alpha-lipoic acid, NADH (nicotinamide adenine dinucleotide), N-acetyl L-cysteine, sodium benzoate, potassium sorbate, xanthan gum, deionized water, glycerin, lecithin hydroxylate, flavor identical to natural strawberry and cream, ektar agave, grapefruit seed extract.
Scope: & nbsp
For realization to the population as a biologically active additive to food - an additional source of vitamins, zinc, selenium, a source of flavonoids (rutin, quercetin).
Suggested Usage: & nbspAT5 ml (1 teaspoon) 1 time a day with meals, previously diluted in 100-200 ml of liquid (water, juice). Shake before use. Duration of admission is 1 month.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store at room temperature.
After opening, the bottle should be stored in a place protected from light, out of reach of children, at a temperature of 4 ° C to 10 ° C.
Research protocols:EExpert conclusion of FGBICU "NII Nutrition" №72 / Э-440 / б-15 of 26.02.2015.
Recipient:AD Medicine, LLCAD Medicine, LLC USA
Information update date: & nbsp05.06.2016
Instructions
Up